Back

Erythropoietin responsiveness and its prognostic association according to sodium–glucose cotransporter 2 inhibitor use in patients with heart failure

28 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Heart failure prevention: pharmacist-led guideline-directed medical therapy and training Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Yu Agata

Hokkaido University Hospital, Sapporo (Japan)

6 More presentations in this session

Presentation thumbnail
Oral ferric maltol in heart failure patients with iron deficiency anaemia according to NYHA functional class
Doctor W. Geller (Hannover, DE)
Abstract Slides Video
Presentation thumbnail
Association of an early multidisciplinary HF pathway and inpatient rehabilitation with 1-year survival: a four-group real-world analysis (2020–2025)
Doctor R. Fujimoto (Tsuyama, JP)
Abstract Slides Video
Presentation thumbnail
Inpatient-initiated and home-based exercise training reduces heart failure hospitalization and reverses frailty: a prospective randomized study
Doctor K. Kim (Incheon, KR)
Abstract Slides
Presentation thumbnail
START-HF: a multi-centre evaluation of centralised pharmacist-led remote GDMT optimisation in HFrEF
Doctor A. Kirupananthavel (London, GB)
Abstract Slides Video
Presentation thumbnail
Trends in utilization and clinical outcomes of sodium-glucose co-transporter 2 inhibitors in patients with heart failure undergoing mitral transcatheter edge-to-edge repair
Doctor A. Qamar (Chicago, US)

Access the full session

Session thumbnail
Heart failure prevention: pharmacist-led guideline-directed medical therapy and training

The Event

Event poster

ESC Congress 2026

28 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Effects of SGLT-2 inhibitors on erythropoiesis and the associated cardio-renal benefits in patients with chronic heart failure
17 May 2025
thumbnail
Congress Presentation
Impact of a pre-discharge checklist on temporal trends in gdmt prescription and clinical events in patients with heart failure
30 August 2026
thumbnail
Congress Presentation
Efficacy of sodium–glucose cotransporter 2 inhibitors in heart failure patients with low body mass index
28 August 2026
thumbnail
Congress Presentation
Intravenous iron therapy outcomes according to deficiency type in heart failure (IRON-HEART)
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources